Text Size

Ultrasound for Perfusion in Neonates

This study has been withdrawn prior to enrollment.
(Study terminated at this time by investigator. Will create new protocol.)
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Jonathan Rubin, M.D., University of Michigan
ClinicalTrials.gov Identifier:
NCT00847951
First received: February 17, 2009
Last updated: June 20, 2012
Last verified: June 2012
History of Changes
  Purpose

The purpose of this study is to evaluate the effectiveness of 3D (3dimensional)renal ultrasound to check kidney perfusion (to see if the kidney is receiving enough blood flow to function as it should) in pre-mature and/or very low birth weight babies.


Condition Intervention
Kidney Perfusion
 Procedure: 3D Ultrasound Imaging

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: 3D Ultrasound for Perfusion in Neonates

Resource links provided by NLM:

MedlinePlus related topics: Ultrasound
U.S. FDA Resources

Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • To determine if ultrasound imaging can accurately help physicians determine if the kidneys are being perfused adequately and determine if the baby is responding to a specific treatment or not. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 0
Arms Assigned Interventions
Renal perfusion in Neonates
Assessing renal perfusion in Neonates.
 Procedure: 3D Ultrasound Imaging
3D renal ultrasound to check kidney perfusion in pre-mature and/or very low birth weight babies.

  Eligibility

Ages Eligible for Study:   up to 28 Days
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Very low birth weight babies in ICU in stable condition and/or premature babies in ICU in stable condition

Exclusion Criteria:

  • Unstable very low birth weight/premature babies
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00847951

Locations
United States, Michigan
University of Michigan Hospital
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
University of Michigan
National Institutes of Health (NIH)
Investigators
Principal Investigator: Jonathan Rubin, MD Univeristy of Michigan Hospital
  More Information

No publications provided

Responsible Party: Jonathan Rubin, M.D., Principal Investigator, University of Michigan
ClinicalTrials.gov Identifier: NCT00847951     History of Changes
Other Study ID Numbers: HUM00021322
Study First Received: February 17, 2009
Last Updated: June 20, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
renal
neonates

ClinicalTrials.gov processed this record on September 26, 2012